US2006009734A1PendingUtilityA1

Dosage control for drug delivery system

47
Individually held — no corporate assignee on recordPriority: Jul 7, 2004Filed: Jul 7, 2004Published: Jan 12, 2006
Est. expiryJul 7, 2024(expired)· nominal 20-yr term from priority
Inventors:James F. Martin
A61M 5/00A61M 31/00A61M 5/14A61M 5/168A61M 2005/14208A61M 5/1723G16H 20/17A61M 5/142
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method for delivering intravenous drugs to a patient comprising programming a drug delivery system, including a controller and an infusion pump, with a maintenance rate or a loading dose for a drug and causing the drug delivery system to (a) calculate a loading dose based on the maintenance rate or a maintenance rate based on the loading dose, (b) administer the loading dose of the drug to the patient to rapidly achieve a desired level of effect, and (c) administer the drug at a first maintenance rate to maintain the level of effect.

Claims

exact text as granted — not AI-modified
1 . A method for delivering intravenous drugs to a patient comprising: 
 programming a drug delivery system including a controller and an infusion pump with a maintenance rate or a loading dose for a drug; causing the drug delivery system to:    (a) calculate a loading dose based on the maintenance rate or a maintenance rate based on the loading dose;    (b) administer the loading dose of the drug to the patient to rapidly achieve a desired level of effect; and    (c) administer the drug at a first maintenance rate to maintain the level of effect.    
     
     
         2 . The method of  claim 1  wherein the step of calculating a loading dose based on the maintenance rate or a maintenance rate based on the loading dose is based on a formula that correlates the maintenance rate and the loading dose recommended by the drug supplier.  
     
     
         3 . The method of  claim 2  wherein the formula is based upon a linear interpolation of the maximum loading dose and the maximum maintenance rate recommend by the drug supplier.  
     
     
         4 . The method of  claim 3  wherein the drug is propofol and the formula is:  
           LD= 0.5* W *( MR/ 75)  
       where, LD=Loading Dose (mg), MR=Maintenance Rate (μg/kg/min), W=Weight (kg) of the patient.  
     
     
         5 . The method of  claim 1  wherein the step of administering the loading dose is performed using an infusion pump at an infusion rate approximately equal to the maximum infusion rate of the pump.  
     
     
         6 . The method of  claim 1  wherein the step of administering the loading dose is conducted by administering the loading dose over a predetermined period.  
     
     
         7 . The method of  claim 1  wherein the drug delivery systems tracks the cumulative loading dose administered to the patient, wherein the cumulative loading dose is calculated based on the formula:  
           LD   —   cum   x   =LD   —   cum   x−1 +amount of  LD  currently delivered in sample  x    
     
     
         8 . The method of  claim 1  wherein the method includes the additional steps of: 
 programming the drug delivery system with a second maintenance rate whereupon the system:    (a) calculates an incremental loading dose for the drug based on the second maintenance rate    (b) administers the incremental loading dose to the patient to rapidly achieve the new desired level of effect; and    (c) administers the drug at the second maintenance rate to maintain the new level of effect.    
     
     
         9 . The method of  claim 8  wherein the incremental loading dose is calculated for the second maintenance rate and the cumulative loading dose based on a formula that correlates the maintenance rate and the loading dose recommended by the drug supplier  
     
     
         10 . The method of  claim 9  wherein the drug is propofol and the incremental loading dose is calculated from the second maintenance rate and the cumulative loading dose based on the formula:  
         Incremental LD=0.5* W *( MR _new/75)− LD   —   cum    
     
     
         11 . The method of  claim 9  wherein the second maintenance rate is increased from the first maintenance rate.  
     
     
         12 . The method of  claim 11  wherein the drug is administered to the patient using an infusion pump and the incremental loading dose is administered at a rate approximately equal to the maximum infusion rate of the pump.  
     
     
         13 . The method of  claim 11  wherein the step of administering the incremental loading dose is conducted by administering the incremental loading dose over a predetermined period.  
     
     
         14 . The method of  claim 9  wherein the second maintenance rate is less than the first maintenance rate.  
     
     
         15 . The method of  claim 14  wherein the incremental loading dose is a negative loading dose.  
     
     
         16 . The method of  claim 15  wherein the negative loading dose is administered by setting a infusion rate to zero for a period of time.  
     
     
         17 . The method of  claim 16  wherein the zero period of time is calculated based on the incremental loading dose.  
     
     
         18 . The method of  claim 17  wherein the zero time period is calculated using the formula:  
         Zero_time=60*1000* LD /( MR*W )  
     
     
         19 . The method of  claim 1  wherein the method further includes the step of administering a transient bolus of the drug to temporarily increase in the patient's level of effect.  
     
     
         20 . The method of  claim 1  wherein the steps of administering are discontinued if adverse physiology is detected  
     
     
         21 . The method of  claim 1  wherein the step of administering is discontinued if adverse physiology is detected during a maintenance rate infusion.  
     
     
         22 . The method of  claim 1  wherein the step of administering is discontinued if adverse physiology is detected during a loading dose infusion.  
     
     
         23 . The method of  claim 1  wherein the method includes reducing the maintenance rate if adverse physiology or an adverse trend in physiology is detected.  
     
     
         24 . The method of  claim 23  wherein the maintenance rate is reduced if adverse physiology or an adverse trend in physiology is detected during a maintenance rate infusion.  
     
     
         25 . The method of  claim 23  wherein the maintenance rate is reduced if adverse physiology or an adverse trend in physiology is detected during a loading dose infusion.  
     
     
         26 . The method of  claim 23  wherein the step of reducing the maintenance rate includes stopping administering the drug and determining the maintenance rate reduction by calculating an apparent maintenance rate at the time the adverse physiology or trend has cleared based on the cumulative loading dose.  
     
     
         27 . The method of  claim 26  wherein the drug is propofol and the maintenance rate reduction is determined by calculating the apparent maintenance rate at the time the adverse physiology or trend has cleared (physiology returns to normal), based on the formula:  
           MR _apparent=75* LD   —   cum /(0.5* W )  
     
     
         28 . The method of  claim 8  wherein the method includes the further step of monitoring the patient's level of effect  
     
     
         29 . The method of  claim 28  wherein the level of effect is the level of sedation  
     
     
         30 . The method of  claim 29  wherein the patient's level of sedation is based on the patient's response to an automated response monitoring system (ARM).  
     
     
         31 . The method of  claim 28  wherein the step of programming of a second maintenance rate is limited based upon the patient's level of effect.  
     
     
         32 . The method of  claim 31  wherein the programming of the second maintenance rate is limited based upon the patient's response to ARM.  
     
     
         33 . The method of  claim 28  wherein the maintenance rate is automatically reduced based on the monitored level of effect.  
     
     
         34 . The method of  claim 33  wherein the maintenance rate is automatically reduced based on the patient's level of sedation.  
     
     
         35 . The method of  claim 34  wherein the maintenance rate is automatically reduced if the patient is not responsive to ARM for a predetermined time.  
     
     
         36 . The method of  claim 35  where the maintenance rate is reduced by 5% if the patient is not responsive to ARM for 15 minutes.  
     
     
         37 . The method of  claim 8  wherein the method includes the step of monitoring the patient's level of effect based on a patient tuned system that gives the patient input to the drug delivery.  
     
     
         38 . The method of  claim 37  wherein the patient tuned system sends a request to the patient to generate a response, wherein the request is a query regarding patient's comfort level.  
     
     
         39 . The method of  claim 38  wherein the patient's level of sedation is monitored based on the patient's response to the request.  
     
     
         40 . The method of  claim 39  wherein the patient's response to the request is used to increase the maintenance rate.  
     
     
         41 . The method of  claim 40  wherein the time it takes for the patient to respond to the request is used calculate the amount the maintenance rate will be increased.  
     
     
         42 . The method of  claim 39  wherein the maintenance rate will be gradually decreased if the patient has not responded to the request for a specified period of time.  
     
     
         43 . A method for sedating a patient comprising: 
 (a) selecting a first maintenance rate or an initial loading dose for a sedation drug;    (b) calculating an initial loading dose based on the maintenance rate or a maintenance rate based on the initial loading dose;    (c) administering the initial loading dose of the sedation drug to the patient to achieve a desired level of sedation;    (d) administering the sedation drug at a first maintenance rate to maintain the level of sedation;    (e) selecting a second maintenance rate to adjust the level of sedation;    (f) calculating an incremental loading dose based on a cumulative loading dose and the second maintenance rate;    (g) calculating the cumulative loading dose administered to the patient based on the formula:        LD   —   cum   x+1   =LD   —   cum   x +amount of  LD  delivered in sample;    (h) administering the incremental loading dose to the patient to achieve a second level of sedation; and    (i) administering the sedation drug at the second maintenance rate to maintain a second level of sedation.    
     
     
         44 . The method of  claim 43  wherein the step of administering the loading dose is performed using an infusion pump at an infusion rate approximately equal to the maximum infusion rate of the pump.  
     
     
         45 . The method of  claim 43  wherein the step of administering the loading dose is conducted by administering the loading dose over a predetermined period.  
     
     
         46 . The method of  claim 43  wherein the second maintenance rate is greater than the first maintenance rate.  
     
     
         47 . The method of  claim 43  wherein the method includes the step of monitoring the patient's level of sedation based on patient's response to an automated responsiveness monitoring system (ARM).  
     
     
         48 . The method of  claim 47  wherein the step of monitoring the level of sedation includes sending a request using the automated responsiveness monitoring system (ARM) to the patient to generate a response, wherein the request is a query regarding the patient's comfort level.  
     
     
         49 . A drug delivery system that delivers a loading dose and a maintenance rate of a drug to a patient, the system including an infusion pump and a controller, the controller being programmed such that the system performs the steps of: 
 (a) calculating a loading dose based on the maintenance rate or a maintenance rate based on the loading dose;    (b) administering the loading dose to the patient to achieve a desired level of effect; and    (c) administering the drug at a first maintenance rate to maintain the level of sedation.    
     
     
         50 . The drug delivery system of  claim 49  wherein the step of calculating a loading dose based on the maintenance rate or a maintenance rate based on the loading dose is based on a formula that correlates the maintenance rate and the loading dose recommended by the drug supplier.  
     
     
         51 . The drug delivery system of  claim 50  wherein the formula is based upon a linear interpolation of the maximum recommended loading dose and the maximum recommended maintenance rate.  
     
     
         52 . The drug delivery system of  claim 49  wherein the controller includes a setting to administer the loading dose by operating the infusion pump at an infusion rate approximately equal to the maximum infusion rate of the pump.  
     
     
         53 . The drug delivery system of  claim 49  wherein the controller includes a setting to administer the loading dose by administering the loading dose over a predetermined period.  
     
     
         54 . The drug delivery system of  claim 49  wherein the drug delivery system tracks the cumulative loading dose administered to the patient, wherein the cumulative loading dose is calculated based on the formula:  
           LD   —   cum   x   =LD   —   cum   x−1 +amount of  LD  currently delivered in sample  x    
     
     
         55 . The drug delivery system of  claim 49  wherein the controller is programmed with a second maintenance rate whereupon the system: 
 (a) calculates an incremental loading dose for the drug based on the second maintenance rate    (b) administers the incremental loading dose to the patient to rapidly achieve the new desired level of effect; and    (c) administers the drug at the second maintenance rate to maintain the new level of effect.    
     
     
         56 . The drug delivery system of  claim 51  wherein the controller is programmed to calculate the loading dose based on the formula:  
           LD= 0.5* W *( MR/ 75)  
       where, LD=Loading Dose (mg), MR=Maintenance Rate (μg/kg/min), W=Weight (kg) of the patient.  
     
     
         57 . The drug delivery system of  claim 51  wherein the controller is programmed to calculate the incremental loading dose based on the formula:  
           Incremental LD= 0.5* W *( MR   —   new/ 75)− LD   —   cum    
     
     
         58 . The drug delivery system of  claim 55  wherein the controller is programmed to administer the incremental loading dose over a predetermined period.  
     
     
         59 . The drug delivery system of  claim 49  where the infusion pump delivers the drug at an infusion rate that can be set to zero for a period of time.  
     
     
         60 . The drug delivery system of  claim 59  wherein the controller is programmed to calculate the zero period of time based on the incremental loading dose.  
     
     
         61 . The drug delivery system of  claim 60  wherein the zero time period is calculated using the formula:  
           Zero   —   time= 60*1000* LD /( MR*W )  
     
     
         62 . The drug delivery system of  claim 49  wherein the controller includes a setting to deliver a transient bolus of the drug to temporarily increase in the patient's level of effect.  
     
     
         63 . The drug delivery system of  claim 49  wherein the system includes sensors for sensing the physiology of the patient and the controller is programmed to discontinue the step of administering the drug if adverse physiology or an adverse trend in physiology is detected.  
     
     
         64 . The drug delivery system of  claim 63  wherein the controller is programmed to calculate a maintenance rate reduction by calculating the apparent maintenance rate at the time the adverse physiology or trend has cleared (physiology returns to normal), based on the formula:  
           MR   —   apparent= 75* LD   —   cum /(0.5* W )  
     
     
         65 . The drug delivery system of  claim 49  wherein the system further includes an automated response monitoring system (ARM).  
     
     
         66 . The drug delivery system of  claim 65  wherein the system further includes a patient response input.

Join the waitlist — get patent alerts

Track US2006009734A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.